Keyphrases
Glucose Metabolism
100%
Topoisomerase Inhibitors
100%
Myeloma Cells
100%
DNA Damage Response
100%
PI3K-AKT-mTOR Signaling
100%
FDG Uptake
80%
DNA Damage
60%
AKT1
60%
Glucose Transporter 1 (GLUT1)
60%
Mammalian Target of Rapamycin (mTOR)
60%
Hexokinase
60%
Cell Survival
40%
Apoptosis Induction
40%
Phosphoinositide 3-kinase (PI3K)
40%
Bortezomib
40%
Molecular Inhibitors
40%
Cell Viability
20%
Combination Treatment
20%
Cancer Treatment
20%
Doxorubicin
20%
Cancer Cells
20%
Western Blotting
20%
Metabolic Pathway
20%
Multiple Myeloma
20%
Cancer Hallmarks
20%
Etoposide
20%
Topotecan
20%
Cancer Cell Lines
20%
Glucose Consumption
20%
Glycolytic Enzymes
20%
Cleaved caspase-3
20%
Aerobic Glycolysis
20%
MK-2206
20%
Cleaved PARP
20%
Altered Glucose Metabolism
20%
Elevated Glucose
20%
Topoisomerase
20%
BEZ235
20%
MTOR Signaling
20%
ATP Assay
20%
NU7026
20%
KU-55933
20%
Promising Strategies
20%
Medicine and Dentistry
Glucose Metabolism
100%
Multiple Myeloma
100%
Topoisomerase Inhibitor
100%
Myeloma Cell
100%
Akt/mTOR Signaling
100%
DNA Damage Response
100%
Fluorodeoxyglucose F 18
80%
Protein Kinase B
80%
Hexokinase
60%
Programmed Cell Death
40%
Cell Survival
40%
Bortezomib
40%
Vincristine
40%
Glucose Transporter 1
40%
Metabolism
20%
Cancer Treatment
20%
Cancer Cell
20%
Western Blot
20%
Poly ADP Ribose Polymerase
20%
Cell Viability
20%
Cancer Cell Line
20%
DNA Damage
20%
Topotecan
20%
Glycolytic Enzyme
20%
Glucose Intake
20%
BEZ235
20%
Kinase
20%
Aerobic Glycolysis
20%
2 Morpholino 6 (1 Thianthrenyl) 4 Pyranone
20%
Adenosine Triphosphate
20%
Etoposide
20%
Doxorubicin
20%
Caspase 3
20%
Glucose Transporter
20%
Biochemistry, Genetics and Molecular Biology
DNA Damage Response
100%
Glucose Metabolism
100%
Akt/mTOR Signaling
100%
Topoisomerase
100%
DNA Topoisomerase
100%
Protein Kinase B
80%
Glucose Transporter
60%
Hexokinase
60%
Cancer Cell
40%
Cell Survival
40%
Programmed Cell Death
40%
Metabolic Pathway
20%
Western Blot
20%
Aerobic Glycolysis
20%
Enzyme
20%
DNA Damage
20%
Cell Viability
20%
Adenosine Triphosphate
20%
Poly ADP Ribose Polymerase
20%
Caspase 3
20%
Doxorubicin
20%
Pharmacology, Toxicology and Pharmaceutical Science
DNA Topoisomerase Inhibitor
100%
Multiple Myeloma
100%
Protein Kinase B
100%
Fluorodeoxyglucose F 18
66%
Malignant Neoplasm
50%
Hexokinase
50%
Bortezomib
33%
Glucose Transporter 1
33%
Vincristine
33%
Cell Viability
16%
Doxorubicin
16%
Western Blot
16%
Etoposide
16%
Dactolisib
16%
Glycolytic Enzyme
16%
2 Morpholino 6 (1 Thianthrenyl) 4 Pyranone
16%
Adenosine Triphosphate
16%
Caspase 3
16%
Topotecan
16%
Glucose Transporter
16%